Skip to main content
RENHE PHARMACY CO.,LTD logo

RENHE PHARMACY CO.,LTD — Investor Relations & Filings

Ticker · 000650 ISIN · CNE000000NF8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,739 across all filing types
Latest filing 2025-10-13 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 000650

About RENHE PHARMACY CO.,LTD

https://www.renheyaoye.com

Renhe Pharmacy Co., Ltd. specializes in the research, development, manufacturing, and distribution of pharmaceutical products and health-related commodities. The company maintains a diverse portfolio encompassing over-the-counter (OTC) medications, traditional Chinese medicines (TCM), health supplements, and personal care items. Its core product lines address various therapeutic areas, including respiratory health, digestive disorders, gynecology, and pediatrics. Renhe is recognized for its established brand equity, operating well-known labels such as Renhe, Youka, and Fuyan. The company integrates modern pharmaceutical technology with traditional medicinal practices to produce high-quality healthcare solutions. Its operations are supported by a comprehensive supply chain and an extensive marketing network, focusing on providing accessible healthcare products to a broad consumer base.

Recent filings

Filing Released Lang Actions
特定对象来访接待管理制度（2025年10月）
Governance Information Classification · 95% confidence The document is a detailed internal policy and procedural manual titled '特定对象来访接待管理制度' (Management System for Reception of Specific Visitors) for a listed company, 仁和药业股份有限公司. It outlines rules and principles for handling visits and communications with specific stakeholders such as investors, analysts, media, and large shareholders. The content focuses on governance, compliance with securities laws, information disclosure fairness, confidentiality, and record-keeping related to investor relations activities. There are no financial statements, earnings data, audit opinions, or regulatory filings of financial results. The document is not an announcement or a brief notice but a comprehensive governance and compliance guideline. It aligns best with Governance Information (CGR), which covers internal rules, board structure, and governance practices. The document length (5121 characters) and detailed procedural content support this classification with high confidence.
2025-10-13 Chinese
战略委员会议事规则（2025年10月）
Governance Information Classification · 100% confidence The document is titled '董事会战略委员会议事规则' which translates to 'Board Strategic Committee Meeting Rules'. It details the structure, responsibilities, and procedures of a board committee, including membership, duties, meeting protocols, and decision-making processes. There is no financial data, no mention of financial results, no regulatory filings, no voting results, no announcements of reports, or any other financial or legal disclosures. The content is focused on governance practices and internal board committee rules. Therefore, this document fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-10-13 Chinese
仁和药业股份有限公司关于召开2025年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice about convening the 2025 first extraordinary general meeting of shareholders (临时股东大会) for Renhe Pharmaceutical Co., Ltd. It includes details about the meeting time, location, agenda items (proposals for amendments to company bylaws and various management systems), voting procedures including online voting, and registration instructions. There is no financial data, earnings information, or audit content. The document is an announcement informing shareholders about the meeting and how to participate, rather than the results of the meeting or the actual report. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2025-10-13 Chinese
对外投资管理制度（2025年10月）
Governance Information Classification · 95% confidence The document is titled '对外投资管理制度' which translates to 'External Investment Management System' and outlines internal policies and procedures for managing external investments by the company. It includes detailed governance, decision-making thresholds, roles and responsibilities, execution controls, investment disposal, and supervision related to external investments. There is no indication that this is a financial report, earnings release, or regulatory filing. It is a governance or internal control document related to investment management policies. It is not a report publication announcement or a certification. Given the content focuses on internal rules and governance practices, the most appropriate classification is Governance Information (CGR). The document length is 4009 characters, which is relatively short but contains substantive policy content rather than a mere announcement.
2025-10-13 Chinese
独立董事工作制度（2025年10月）
Governance Information Classification · 95% confidence The document is a detailed internal governance policy regarding the independent director system of a company, including qualifications, duties, nomination, election, and protections for independent directors. It references relevant laws, regulations, and stock exchange rules but does not contain financial statements, audit results, or financial performance data. It is a governance-related document focused on board structure and director responsibilities rather than a financial report or announcement. Therefore, it fits best under Governance Information (CGR). The document length and content confirm it is the full policy text, not a brief announcement or summary.
2025-10-13 Chinese
内部审计工作制度（2025年10月）
Governance Information Classification · 95% confidence The document is titled '内部审计制度' (Internal Audit System) for a company, detailing the internal audit policies, responsibilities, organizational structure, procedures, and accountability mechanisms. It is a comprehensive internal control and audit policy document, not a financial report, earnings release, or announcement. It does not contain financial statements or results, nor is it a notice or announcement of a report. It is a governance-related document describing internal audit rules and procedures, which aligns with governance information about company internal rules and board practices. Therefore, the most appropriate classification is Governance Information (CGR).
2025-10-13 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.